SQUAWK/NEWS
Menu
Live News EQUITY L impact

Karyopharm Files SEC Form

Karyopharm Therapeutics submits regulatory filing with SEC. No details disclosed.

KPTI

Filed: 2026-05-26 AccNo: 0001254705-26-000008 Size: 5 KB